Evaluation of type 2 Diabetes Mellitus Risk in Patients with post Trauma Splenectomy by Nemati Honar, Behzad et al.
Men’s Health Journal. 2021; 5(1): e15
ORIGINAL RESEARCH
Evaluation of type 2 Diabetes Mellitus Risk in Patients with
post Trauma Splenectomy
Behzad Nemati Honar1, Mehdi Pishgahi2, Mohammad Mehdi Forouzanfar3, Seyed Ali Forouzannia4, Seyed
Alireza Ebadi5∗, Mohammad Karim Shahrzad6†
1. Department of General Surgery, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2. Cardiology Department, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3. Department of Emergency Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4. Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5. Department of Internal Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
6. Internal Medicine and Endocrinology, Shohada Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Received: January 2021; Accepted: February 2021; Published online: March 2021
Abstract: Introduction: Recent studies suggest that the spleen has an important role as a source of multipotent stem
cells and precursors of beta cells of pancreas islets. In addition, increased risk of developing hyperglycemia
was reported in patients who underwent splenectomy due to trauma in long-term follow up. Therefore, there
might be an association between splenectomy and an increased risk of type 2 diabetes mellitus. In this study,
we evaluated the risk of type 2 diabetes and its risk factors including hyperglycemia, dyslipidemia, obesity and
hypertension in trauma patients with splenectomy. Materials and methods: In this study, 221 patients who
underwent splenectomy surgery due to trauma in the surgical ward of Imam Hossein Hospital 5 to 10 years
ago were selected. Those with a history of diabetes, cancer, hyperthyroidism, Cushing’s syndrome, pancreatitis,
renal failure, and cirrhosis were excluded from the study. Then fasting plasma glucose, hemoglobin A1c (HbA1c),
triglyceride, cholesterol and high density lipoprotein (HDL), body mass index and blood pressure have been
evaluated in 90 patients who had had a history of splenectomy due to trauma from 2007, July 23 to 2012, July 22.
Results: The results indicate that none of these patients has diabetes, 14.4 percent are in pre-diabetic stage, 56.6
percent has dyslipidemia, 57.7 percent has obesity and 20 percent has hypertension. Conclusion: The results
of this study suggest that splenectomy does not increase the risk of type 2 diabetes. Prevalence of diabetes risk
factors was approximately the same with those of Tehran population.
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1. Introduction
Diabetes mellitus includes a group of common metabolic
disorders, all of which have the hyperglycemic phenotype.
The prevalence of the disease has increased dramatically in
the past two decades, from about 30 million in 1985 to about
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422 million in 2020. Diabetes mellitus is classified into two
categories: type 1 diabetes mellitus (T1DM) and type 2 dia-
betes mellitus (T2DM). T1DM is the result of partial or com-
plete insulin deficiency, and T2DM is a heterogeneous group
of disorders characterized by varying degrees of insulin resis-
tance, impaired insulin secretion, and increased glucose pro-
duction. The abnormal stage of glucose homeostasis before
T2DM is classified as impaired fasting glucose (IFG) and im-
paired glucose tolerance (IGT). (1)
Current criteria for diagnosing diabetes are fasting plasma
glucose and hemoglobin A1C tests. Risk factors for T2DM in-
clude; family history, obesity (body mass index (BMI) equal
to or greater than 25), lack of physical activity, previous diag-
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nosis of IFG or hemoglobin A1c between 5.7 and 6.4, history
of gestational diabetes, hypertension, dyslipidemia, Polycys-
tic ovary syndrome and cardiovascular disease. (1)
Glucose homeostasis reflects the balance between hepatic
glucose production and peripheral glucose uptake and con-
sumption. Insulin is the most important regulator of this
metabolic balance that is produced in the beta cells of the
pancreatic islets. (1)
Despite the great importance of the spleen in the immune
system and blood circulation, in trauma patients with low
blood pressure and a high degree of spleen damage, splenec-
tomy is performed quickly. New evidence suggests that the
spleen plays a role as a source of adult multipotent stem cells,
which may migrate to the pancreas and become insulin-
secreting beta cells. (2-4)
If this hypothesis is correct, it may be necessary to raise
awareness to maintain spleen or diabetes mellitus after
splenectomy. Research on the role of splenectomy in dia-
betes mellitus has shown that in animal specimens there is
a link between the spleen and the endocrine part of the pan-
creas (5, 6), and in children and adults there is a link between
splenectomy and insulin resistance and other endocrine dis-
orders. (7-12)
The difference between this study and previous studies on
the association between splenectomy and diabetes is that
in addition to hyperglycemia, we also examined other risk
factors for diabetes in the patient population, such as over-
weight and obesity, hypertension, and dyslipidemia.
Based on the results of recent research cited, in this study
we intend to answer the question of whether the long-term
risk of T2DM is increased in patients who have undergone
splenectomy after trauma. The results of this study are useful
in this field, which leads to increased awareness for decision-
making to maintain the spleen when it is possible for the pa-
tient.
Our hypothesis is that splenectomy increases the risk of
T2DM in these patients. To test this hypothesis, 90 patients
who underwent trauma at Imam Hossein Hospital 5 to 10
years ago were selected and we will examine the risk factors
for diabetes and blood sugar in them.
2. Materials and Methods
To conduct a descriptive study, to evaluate the increased risk
of T2DM in patients undergoing splenectomy due to trauma,
221 patients who underwent splenectomy surgery in the sur-
gical ward of Imam Hossein Hospital from 2007, July 23 to
2012, July 22 were selected and evaluated for hyperglycemia,
T2DM and risk factors for diabetes and the coexistence of
obesity, hypertension and dyslipidemia. Those with a history
of diabetes, cancer, hyperthyroidism, Cushing’s syndrome,
pancreatitis, renal failure, and cirrhosis, were excluded from
the study, the high blood sugar level may be the result of the
mentioned illnesses or medications. Also, patients who had
any pancreatic damage reported by the surgeon during their
abdominal exploration were excluded from the study.
Patients who did not have diabetes or any other significant
disease at the time of splenectomy surgery and whose pan-
creas was not damaged, as well as between the ages of 15 and
50 at the time of surgery, were selected for the study.
Considering the ethical considerations in the research and
explaining that according to recent studies, there may be a
connection between splenectomy and long-term glycemic
control disorder, they were invited to participate in this study.
Eventually, 99 people came to the hospital to visit the doctor
and perform tests.
To collect patient information, a form was prepared that
recorded patient information in three sections: history, ex-
amination, and lab tests results. Patients were asked about
their history of diabetes symptoms (polyuria, polydipsia,
weight changes), family history, dyslipidemia, hyperten-
sion, smoking, gestational diabetes, and history of polycystic
ovaries. Drugs taken by the patient were also asked, and pa-
tients taking hyperglycemic drugs such as beta-blockers, cor-
ticosteroids, phenytoin, Diaz oxide, thiazide, and olanzapine
were excluded from the study. Patients’ body mass index and
blood pressure were measured in the examination section. In
the lab tests section, fasting blood sugar (FBS), hemoglobin
A1C, triglyceride, cholesterol, HDL tests were requested for
patients and the results were recorded. Finally, data were col-
lected from 90 patients (38 females and 52 males) who under-
went splenectomy after trauma, who were between 20 and 55
years old at the time of the study and did not take the drug
that causes hyperglycemia, and were analyzed for data.
SPSS software version 22 was used. Indicators such as
standard deviation, mean and mode were examined and
recorded separately for each data. T-test was used to examine
the relationship between data mean and community mean
and probability value was calculated for each variable. The
error rate was 5%, which means P-values of 0.05 or less were
considered statistically significant.
3. Results
The study looked at 38 women and 52 men between the ages
of 20 and 55. The results of this study showed that these
people did not develop T2DM in 5 to 10 years after splenec-
tomy, although in 14.4% of people IFG or hemoglobin A1C
between 5.7 and 6.4 was observed. And 13 patients were in
the pre-diabetes stage. Also, 56.6% of these patients had dys-
lipidemia. 20% of these patients had hypertension. 57.7%
of patients was overweight and obese. There was no history
of gestational diabetes mellitus (GDM) and polycystic ovary
(PCO) in female patients and there was a family history of di-
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abetes in 11.11% of patients.
In the data obtained with SPSS statistical software for each of
the variables including: Diastolic blood pressure (DBP), Sys-
tolic blood pressure (SBP), body mass index (BMI), high den-
sity lipoprotein (HDL), Cholesterol, Triglyceride, HbA1c and
FBS; the probable value (P-value) was equal to 0.001. It indi-
cates that the relationship between variables and their mean
is strongly related to the mean of the society.
4. Discussion
This study shows that none of the patients who underwent
splenectomy had T2DM in 5 to 10 years after surgery. But in
14.4% of patients, there was at least one in two cases of IFG
or hemoglobin A1C between 5.7 and 6.4. As a result, it cannot
be concluded that splenectomy has increased the prevalence
of diabetes mellitus in the long run.
According to the Iranian Lipid and Glucose Study, the preva-
lence of DM is 14% of people. Every year, 4% of the total
adult population of Tehran changes from healthy blood sugar
to pre-diabetes, and the incidence of diabetes is 1% of the
population in the year. According to the results of the last
stage of these studies, the prevalence of pre-diabetes stage is
reported to be 14.6%. (13) Animal models of diabetes mel-
litus suggest a relationship between the spleen and the en-
docrine part of the pancreas. In one study, avian spleen
embryonic cells were used to grow insulin-producing cells,
which demonstrates the successful transformation and dif-
ferentiation of spleen cells into insulin-producing cells and
suggests that the spleen could be the ideal source of autolo-
gous for transplantation in children who have recently been
diagnosed with T1DM. (6)
In one study, children with severe thalassemia who needed
a splenectomy were examined who developed insulin resis-
tance(7). In another case, a patient who underwent splenec-
tomy as a child developed endocrine dysfunction, which may
be due to the absence of multifocal stem cells(8). It is im-
portant to note that the splenectomies studied in these stud-
ies were performed in childhood and that the development
of the pancreas may be prone to be affected by other dis-
eases after splenectomy. In two adult-specific studies, pa-
tients who underwent splenectomy and pancreatectomy for
chronic pancreatitis were more likely to develop DM than
those who underwent splenectomy. (9, 10)
A study in the California Department of Hospital Surgery
examined the association between post-traumatic splenec-
tomy and hyperglycemia in a retrospective review and co-
hort. In this study, blood glucose in trauma patients with
splenectomy who had been followed for at least 5 years was
compared with trauma patients who required laparotomy
and bowel repair. 9 patients who underwent splenectomy af-
ter trauma and were followed for at least 5 years as an experi-
mental group and 12 patients who underwent bowel surgery
after trauma and were followed for 5 years as a control group
in this study. The mean blood glucose in splenectomy pa-
tients was higher than the control group and 4 people in the
first group had blood sugar above 130. (11)
In another study, 3,723 patients who underwent splenectomy
showed nearly twice as high risk of developing diabetes as
those who underwent other abdominal surgeries. (12) The
difference between this study and previous studies on the re-
lationship between splenectomy and diabetes is that in ad-
dition to hyperglycemia, we also examined other risk factors
for T2DM in the patient population, such as overweight and
obesity, hypertension and dyslipidemia. Due to limited re-
search time, it was not possible to study patients for a long
time. The results of this study may lead to different results
in longer follow-up of patients; because, as mentioned ear-
lier, the onset of T2DM is insulin resistance, and over time,
in some patients with T2DM for a long time, beta cell mass
decreases by nearly 50% in individuals.
It is recommended that a prospective cohort study be per-
formed to investigate the increased risk of developing type
2 diabetes to the stage of insulin dependence in diabetic
splenectomy patients and diabetic patients with spleen.
5. Conclusion
This study showed that, contrary to previous studies, in pa-
tients who did not have other risk factors for diabetes and
their pancreas was not damaged during splenectomy, there
was no overall increased risk of T2DM in these patients com-
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